Table 7.
The comparison of E-cadherin expression in EOC versus BOT patients.
| Number of Patients |
E-Cad Positive Expression n(%) |
p Value | IRS | p Value | Localization | Cutoff [%] | Ref |
|---|---|---|---|---|---|---|---|
| EOC = 39 BOT = 9 |
8 12 * |
0.024 | NL | 10 | [30] | ||
| EOC = 95 BOT = 23 |
79 (83) 23 (100) * |
0.05 |
M | 10 | [32] | ||
| EOC = 136 BOT = 45 |
120 (88) # 7 (16) |
<0.0001 | NL | 6 | [45] | ||
| EOC = 75 BOT = 23 |
124.1 ± 92.9 123.8 ± 106.8 |
ns | C | Nd | [53] | ||
| EOC = 68 BOT = 14 |
52 (76) 10 (71) |
ns | NL | Nd | [56] | ||
| EOC = 46 BOT = 13 |
28 (61) 6 (78) |
=0.22 | NL | 10 | [58] | ||
| EOC = 63 BOT = 7 |
4.98 ± 0.68 # 2.71 ± 1.14 |
≤0.05 | NL | 1 | [68] | ||
| EOC = 30 BOT = 30 |
25 (83) 30 (100) * |
<0.05 |
M | 1 | [71] | ||
| EOC = 31 BOT = 12 |
1.61 ± 1.17 7.58 ± 2.97 * |
<0.01 | M | 25 | [72] | ||
| EOC = 78 BOT = 17 |
25 (32) 5 (29) |
=0.062 | M | 50 | [73] |
Ns—not significant; nd—no data; NL—not localized; M—membranous; C—cytoplasmic; M + C—membranous + cytoplasmic (total). * significantly higher E-cadherin expression in BOT versus EOC patients; # significantly higher E-cadherin expression in EOC versus BOT.